Nisa Investment Advisors
NAUT icon

Nisa Investment Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History

Nisa Investment Advisors’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-283
Closed -$205 – 3049
2025
Q2 		$205 Sell
283
-417
-60% -$313 ﹤0.01% 2999
2025
Q1 		$603 Buy
700
+608
+661% +$904 ﹤0.01% 2760
2024
Q4 		$155 Sell
92
-47
-34% -$112 ﹤0.01% 2965
2024
Q3 		$396 Sell
139
-63
-31% -$163 ﹤0.01% 2760
2024
Q2 		$473 Buy
202
+187
+1,247% +$488 ﹤0.01% 2699
2024
Q1 		$44 Hold
15
– – ﹤0.01% 2751
2023
Q4 		$45 Sell
15
-8,970
-100% -$25.7K ﹤0.01% 2632
2023
Q3 		$28.4K Hold
8,985
– – ﹤0.01% 1900
2023
Q2 		$34.8K Buy
8,985
+7,770
+640% +$22.4K ﹤0.01% 1875
2023
Q1 		$3K Buy
1,215
+1,200
+8,000% +$2.52K ﹤0.01% 2289
2022
Q4 		$0 Buy
+15
New +$29 ﹤0.01% 2661

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nisa Investment Advisors's NAUT Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Nautilus Biotechnolgy (NAUT) in Q3 2025, closing a stake of 283 shares — an estimated $205 sold.

Nisa Investment Advisors first reported a position in NAUT in Q4 2022 and held it in 11 quarters. The position peaked at $34.8K in Q2 2023. 68 funds tracked by Wall St. Rank hold NAUT as of Q3 2025.

  • Nisa Investment Advisors reported no remaining Nautilus Biotechnolgy position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 283 Nautilus Biotechnolgy shares in Q3 2025, an estimated $205.
  • Nisa Investment Advisors first reported a position in Nautilus Biotechnolgy in Q4 2022 and held it in 11 quarters.
  • Nisa Investment Advisors's Nautilus Biotechnolgy position peaked at $34.8K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.